These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8105672)

  • 21. Heterozygous Familial Hypercholesterolemia.
    Onorato A; Sturm AC
    Circulation; 2016 Apr; 133(14):e587-9. PubMed ID: 27045133
    [No Abstract]   [Full Text] [Related]  

  • 22. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe familial hypercholesterolaemia: current and future management.
    Farnier M; Bruckert E
    Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
    Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
    Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heterozygous familial hypercholesterolemia].
    Özcan ÖU; Güleç S
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():10-8. PubMed ID: 25693359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sonographic detection of xanthomas in normal-sized Achilles' tendons of individuals with heterozygous familial hypercholesterolemia.
    Bude RO; Nesbitt SD; Adler RS; Rubenfire M
    AJR Am J Roentgenol; 1998 Mar; 170(3):621-5. PubMed ID: 9490941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple Ligation-dependent Probe Amplification Along with Whole Exome Sequencing Should be Required for the Diagnosis of Structural Heterozygous Familial Hypercholesteremia.
    Saotome M; Maekawa Y
    Intern Med; 2022; 61(19):2829-2830. PubMed ID: 36184533
    [No Abstract]   [Full Text] [Related]  

  • 28. Peripheral arterial disease in heterozygous familial hypercholesterolemia.
    Pereira C; Miname MH; Makdisse MR; Watanabe C; Pesaro AE; Jannes CE; Kalil Filho R; Pereira AC; Santos RD
    Atherosclerosis; 2015 Sep; 242(1):174-8. PubMed ID: 26201001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.
    Civeira F;
    Atherosclerosis; 2004 Mar; 173(1):55-68. PubMed ID: 15177124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
    Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
    Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients' attitudes toward detection of heterozygous familial hypercholesterolemia.
    Andersen LK; Jensen HK; Juul S; Faergeman O
    Arch Intern Med; 1997 Mar; 157(5):553-60. PubMed ID: 9066460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipid metabolism disorders--diagnosis and therapy in general practice. 1: Hypercholesterolemia].
    Richter WO
    Fortschr Med; 1996 Apr; 114(11):133-4. PubMed ID: 8682426
    [No Abstract]   [Full Text] [Related]  

  • 33. Defining the challenges of familial hypercholesterolemia screening: introduction.
    Hopkins PN
    J Clin Lipidol; 2010; 4(5):342-5. PubMed ID: 21122675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seven-year clinical follow-up of a Chinese homozygous familial hypercholesterolemia child with premature xanthomas and coronary artery disease--a need for early diagnosis and aggressive treatment.
    Jiang L; Gao F; Hu LB; Sun LY; Pan XD; Lin J; Zhang HB; Yong Q; Wang Q; Yang Y; Wang CM; Yang SW; Zhang F; Wang LY
    Int J Cardiol; 2014 Nov; 177(1):188-91. PubMed ID: 25499375
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge.
    Vuorio AF; Kovanen PT; Gylling H
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):405-15. PubMed ID: 15151486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-filtration plasmapheresis in heterozygous familial hypercholesterolemia: our experience over 25 treatments.
    Candrina R; Spandrio S; Di Stefano O; Scalvini T; Cotelli M; Tosoni M; Giustina G
    Beitr Infusionsther; 1988; 23():189-90. PubMed ID: 2484776
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic risk factors in the development of heart disease: familial hypercholesterolemia and hyperhomocysteinemia.
    LaCharity LA
    AACN Clin Issues; 1998 Nov; 9(4):531-8. PubMed ID: 9855863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening for familial hypercholesterolemia].
    Cariou B; Krempf M
    Rev Prat; 2011 Oct; 61(8):1106-7. PubMed ID: 22135978
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of gene mutations allows for the molecular diagnosis of familial hypercholesterolemia.
    Retief AE; Kotze MJ; Oosthuizen CJ
    S Afr Med J; 1989 Aug; 76(3):121. PubMed ID: 2762943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.